Intuitive Surgical, Inc. (ISRG)
Automate Your Wheel Strategy on ISRG
With Tiblio's Option Bot, you can configure your own wheel strategy including ISRG - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ISRG
- Rev/Share 28.3593
- Book/Share 48.0194
- PB 10.0388
- Debt/Equity 0.0
- CurrentRatio 4.7279
- ROIC 0.1458
- MktCap 171667226320.0
- FreeCF/Share 6.3998
- PFCF 75.581
- PE 59.5079
- Debt/Assets 0.0
- DivYield 0
- ROE 0.1672
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 3
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | ISRG | TD Cowen | -- | Buy | -- | $660 | Jan. 27, 2026 |
| Downgrade | ISRG | Citigroup | Buy | Neutral | -- | $635 | Dec. 11, 2025 |
| Downgrade | ISRG | Erste Group | Buy | Hold | -- | -- | July 23, 2025 |
| Downgrade | ISRG | Deutsche Bank | Hold | Sell | -- | $440 | June 9, 2025 |
| Upgrade | ISRG | Erste Group | Hold | Buy | -- | -- | June 5, 2025 |
News
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
ISRG's da Vinci Gets FDA Nod for Advanced Cardiac Procedures
Published: January 27, 2026 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical wins FDA 510(k) clearance for the da Vinci 5 system in select cardiac procedures to expand minimally invasive heart surgery.
Read More
China Remains Competitive: Can ISRG Defend Share Amid Local Rivals?
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Negative
ISRG faces slower China tenders, local favoritism and pricing pressure, even as clinicians prefer da Vinci and management flags 2026 competition.
Read More
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Read More
ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines
Published: January 23, 2026 by: Zacks Investment Research
Sentiment: Neutral
Intuitive Surgical stock gains after Q4 EPS and revenue top estimates as system placements and procedure growth offset a decline in gross margin.
Read More
Intuitive Surgical Just Proved the Growth Engine Still Runs
Published: January 23, 2026 by: MarketBeat
Sentiment: Positive
Robotic-assisted surgery stalwart Intuitive Surgical NASDAQ: ISRG blew investors away with its Q3 2025 earnings report back in October 2025. Shares closed up nearly 14% in reaction to the results, marking the healthcare stock's largest single-day post-earnings gain in recent memory.
Read More
These Analysts Revise Their Forecasts On Intuitive Surgical After Q4 Results
Published: January 23, 2026 by: Benzinga
Sentiment: Positive
Intuitive Surgical Inc (NASDAQ: ISRG) reported better-than-expected financial results for the fourth quarter after the market close on Thursday.
Read More
Intuitive Surgical (ISRG) Reports Q4 Earnings: What Key Metrics Have to Say (Revised)
Published: January 23, 2026 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Intuitive Surgical (ISRG) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
More Upside For ISRG Stock?
Published: January 23, 2026 by: Forbes
Sentiment: Positive
Intuitive Surgical reported strong Q4 2025 outcomes with adjusted EPS of $2.53, exceeding estimates of $2.26 and increasing by 14.5% from Q4 2024's $2.21. Revenue reached $2.87 billion, a 19% increase year-over-year that surpassed the consensus of $2.75 billion, while full-year revenue hit $10.1 billion (+21%) coupled with adjusted EPS of $8.93.
Read More
20 Million Patients Benefit from da Vinci Surgery Globally
Published: January 23, 2026 by: GlobeNewsWire
Sentiment: Neutral
Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of Intuitive's minimally invasive technologies Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of Intuitive's minimally invasive technologies
Read More
Jobless Claims Come in Slightly Higher
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Negative
Jobless Claims Come in Slightly Higher.
Read More
Jobless Claims Stay Low at +200K, Q3 GDP Up to +4.4%
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Positive
Weekly Jobless Claims continue to portray a labor market cruising along at a healthy low rate of unemployment claims.
Read More
ISRG vs. MDT: Which MedTech Stock Is a Better Bet Now?
Published: January 21, 2026 by: Zacks Investment Research
Sentiment: Neutral
Intuitive Surgical's pure-play robotics focus, rising da Vinci 5 utilization and 85% recurring revenues tilt the risk-reward versus diversified Medtronic.
Read More
Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now?
Published: January 20, 2026 by: Zacks Investment Research
Sentiment: Negative
ISRG heads into Q4 earnings with 18% procedure growth and da Vinci 5 demand, but valuation and tariffs keep the earnings outlook uncertain.
Read More
2 Healthcare Names That Could Get a Big Boost From Earnings
Published: January 20, 2026 by: MarketBeat
Sentiment: Positive
Active traders expect companies in the healthcare sector to experience significant share price spikes tied to milestones in the development of new therapies and medical products. The volatility in some corners of the sector makes it a high-risk, but high-reward, opportunity.
Read More
Is PODD A Better Bet Than ISRG Stock?
Published: January 19, 2026 by: Forbes
Sentiment: Neutral
PODD is Intuitive Surgical's counterpart in the Health Care Equipment sector that has:
Read More
AI, Digital Tools and Hub Data: Could ISRG Evolve Beyond Robotics?
Published: January 19, 2026 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical is positioning da Vinci 5 as a data-driven platform, using AI, software and surgical data to expand beyond robotics into insights.
Read More
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results
Published: January 16, 2026 by: Zacks Investment Research
Sentiment: Negative
ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, margins and outlook.
Read More
Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder
Published: January 16, 2026 by: Seeking Alpha
Sentiment: Positive
Intuitive Surgical continues robust double-digit growth, with Q4 2025 revenues up 19% y/y and strong da Vinci 5 adoption. The firm's 2026 procedure growth guidance of 13–15% disappointed versus expectations, triggering a recent share sell-off despite operational strength. Elevated multiples reflect the company's market dominance, but tactical buying on dips remains warranted for long-term growth investors.
Read More
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet
Published: January 16, 2026 by: Zacks Investment Research
Sentiment: Neutral
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
Intuitive Surgical (ISRG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Published: January 16, 2026 by: Zacks Investment Research
Sentiment: Neutral
Get a deeper insight into the potential performance of Intuitive Surgical (ISRG) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Read More
Intuitive Surgical, Inc. (ISRG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Published: January 14, 2026 by: Seeking Alpha
Sentiment: Neutral
Intuitive Surgical, Inc. (ISRG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Read More
Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results
Published: January 14, 2026 by: GlobeNewsWire
Sentiment: Neutral
SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial results ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.
Read More
Can da Vinci 5 Expand Intuitive Surgical's TAM Beyond Core Surgeries?
Published: January 09, 2026 by: Zacks Investment Research
Sentiment: Positive
ISRG is positioning da Vinci 5 as a TAM expander, targeting cardiac surgery long term while advancing near-term regulatory steps in general surgery.
Read More
Intuitive Surgical: An Easy 'Buy And Hold' For Long-Term Outperformance
Published: January 09, 2026 by: Seeking Alpha
Sentiment: Positive
Intuitive Surgical, Inc. dominates surgical robotics with an 80% global share and a robust, recurring-revenue business model anchored by the da Vinci platform. ISRG's installed base and procedure volumes continue double-digit growth, driven by superior clinical outcomes and high hospital switching costs. Despite premium valuation (forward P/E ~64), ISRG's pristine balance sheet, strong margins, and relentless innovation justify a long-term Buy rating.
Read More
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
Published: January 07, 2026 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now?
Published: January 07, 2026 by: Zacks Investment Research
Sentiment: Positive
ISRG trades just 4% below its record high after a 32% surge over the past three months, driven by strong procedure growth, rising utilization, and early traction for the da Vinci 5 system.
Read More
Top Robotics Stocks That Could Drive Impressive Returns in 2026
Published: January 06, 2026 by: Zacks Investment Research
Sentiment: Positive
Robotics is poised for steady growth in 2026. Consider PATH, NVDA, CDNS and ISRG for potential market dominance across sectors.
Read More
ISRG Sees 91% SP Growth: A Turning Point for Single-Port Surgery?
Published: December 31, 2025 by: Zacks Investment Research
Sentiment: Positive
ISRG's single-port platform posts 91% procedure growth, led by Korea, with U.S. momentum building as new tools and indications expand adoption.
Read More
Intuitive Surgical vs. Stryker: Which MedTech Stock Has More Upside?
Published: December 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical's robotics-first model, recurring revenue base, and margin leverage differentiate it from Stryker in terms of upside potential today.
Read More
About Intuitive Surgical, Inc. (ISRG)
- IPO Date 2000-06-16
- Website https://www.intuitive.com
- Industry Medical - Instruments & Supplies
- CEO David J. Rosa
- Employees 15638